Document is current
Any future updates will be listed below
-
Authors
Zhang, Jianyi Jay
Pogwizd, Steven M.
Fukuda, Keiichi
Zimmermann, Wolfram-Hubertus https://orcid.org/0000-0003-1190-4040
Fan, Chengming https://orcid.org/0000-0003-0497-1798
Hare, Joshua M.
Bolli, Roberto
Menasché, Philippe
- License Information
-
More Information
Article History
Accepted: 15 October 2024
First Online: 15 November 2024
Competing interests
: K.F. is the cofounder of and has substantial equity in HeartSeed Inc. W.-H.Z. is a founder of and adviser for Repairon GmbH. J.M.H. has a patent for cardiac cell-based therapy and holds equity in Vestion Inc. and maintains a professional relationship with Vestion Inc. as a consultant and member of the Board of Directors and Scientific Advisory Board. Vestion Inc. did not have a role in the design, conduct or funding of this Review. J.M.H. is the Chief Scientific Officer, a compensated consultant and board member for Longeveron Inc. and holds equity in the company; is the co-inventor of intellectual property licensed to Longeveron Inc. Longeveron Inc. did not have a role in the design, conduct or funding of this Review. The University of Miami is an equity owner in Longeveron Inc., which has licensed intellectual property from the University of Miami. The other authors declare no competing interests.
